SoftOx Solutions AS — Share Issue/Capital Change 2020

Dec 18, 2020

SoftOx Solutions AS: Raised NOK 50 million after stock exchange closing Wednesday December 16th - More than 100% oversubscribed

SoftOx Solutions AS: Raised NOK 50 million after stock exchange closing Wednesday December 16th - More than 100% oversubscribed

SoftOx Solutions raised NOK 50 million through its private placement after the stock exchange closing on Wednesday, December 16th. The interest for the capital increase was high, and more than 100 percent oversubscribed.

- This demonstrates that we have confidence in the market, that we are on the right track and it will give us the power we need for our future plans. We are experiencing exciting times at SoftOx, both in product development and commercialization in Norway and internationally, says CEO Geir Almås of SoftOx Solutions.

This capital increase will contribute to further research, including the ongoing lung studies at the University of Copenhagen, where the company's goal is to start testing in humans early 2021.

The company will now also be able to intensify its activities related to the investment in its alcohol-free and skin-friendly hand sanitizers AntiVir and SafeDes towards several large markets in Europe and Asia.

Practical information regarding the capital Increase

The private placement is divided into two tranches: tranche 1 consists of 500,000 shares and tranche 2 with 409 090 shares. It is also proposed to offer a repair issue (subject to approval by the company's General Assembly which is tentatively scheduled to meet on January 4th, 2021) directed at those shareholders who did not subscribe for shares on December 16th in the private placement. Up to NOK 10 million will be raised in the repair issue at the same subscription price (NOK 55.00).

The purpose of the proposed repair issue is to give shareholders who did not get the chance to participate in the private placement the opportunity to subscribe to the same terms as in the private placement - and thus in part "repair" the dilution of ownership.

Oslo, December 18th 2020

Contact:

Geir Almås, CEO of SoftOx Solutions AS

Mail: geir.almaas@soft-ox.com

Mobile: +47 977 59 071

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on the Oslo Stock Exchange Euronext Growth) is a Norwegian MedTech company based in Oslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com